GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Global Health Ltd

Global Health Ltd: 3,14,000 ESOPs granted; Sr. VP HR resigns

MANAGEMENT ▲ Positive Development LOW RISK
📅 Filed on BSE: 02 Nov 2026, 05:29 PM IST  ·  BSE ID: 6ed5643c-2d50-4cba-80e1-564940731a08
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is giving employees stock options and accepted the resignation of its Head of HR.
🤖 AI Summary
  • Global Health Limited approved grant of 3,14,000 ESOPs at Rs. 635 per share.
  • ESOPs granted under the GHL Employees Stock Option Scheme, 2024.
  • Mr. Saurabh Upadhyay, Sr. VP & Head-HR, has resigned from the company.
  • Mr. Upadhyay's last working day is December 23, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
ESOPs Granted
3,14,000
Exercise Price
Rs. 635 Per Share
Last Working Day of Mr. Saurabh Upadhyay
December 23, 2026
🏢 How This Affects the Company
📈
Business Impact
Granting ESOPs can incentivize employees to align with company performance. The departure of a senior HR executive may impact human capital management strategies.
💰
Financial Impact
ESOP grants represent a future dilution of equity. The financial impact will depend on the vesting and exercise of these options.
⚙️
Operational Impact
The resignation of the Head of HR necessitates a search for a new leader for the department and may involve a transition period.
⚠️
Risk Impact
High employee turnover in senior roles can pose operational and strategic continuity risks.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this announcement.
👤
Who Is Affected
Eligible employees who are granted ESOPs will be directly affected by the terms of the grant. All shareholders are indirectly affected by management changes.
🔍
Management Signal
The ESOP grant indicates management's commitment to incentivizing employees. The resignation signals a change in senior leadership personnel.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Appointment of new Sr. VP & Head-HR.
Future ESOP grants under the GHL LTIP 2024 Plan.
Company's subsequent financial results for performance tracking.
LOW RISK ESOP grant is routine. Resignation has a defined exit date.
💡 Investor Takeaway
Global Health Ltd granted 3,14,000 ESOPs at Rs. 635 per share. Concurrently, Sr. VP & Head-HR, Mr. Saurabh Upadhyay, resigned, with his last day being December 23, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Grant of 3,14,000 ESOPs incentivizes employee retention and performance under the GHL LTIP 2024 Plan.
  • Exercise price of Rs. 635 per share provides a defined participation cost for eligible employees.

⚠️ Concerns

  • Resignation of Senior Vice President & Head-HR may indicate internal challenges or a desire for career advancement elsewhere.
  • Departure of a key senior management personnel can lead to a temporary disruption in strategic HR initiatives.
📅 Company Track Record
Previous filings show Global Health Ltd announced management changes, including director resignations and appointments, and approved dividends and Q1 FY27 results in prior periods.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many ESOPs did Global Health Limited approve?
Global Health Limited approved the grant of 3,14,000 ESOPs under the GHL LTIP 2024 Plan.
What is the exercise price for the approved ESOPs?
The ESOPs were approved at an exercise price of Rs. 635 per share.
Who resigned from Global Health Limited's senior management?
Mr. Saurabh Upadhyay, Senior Vice President & Head-HR, has resigned from the company.
When is Mr. Saurabh Upadhyay's last day at Global Health Limited?
Mr. Saurabh Upadhyay's last working day will be December 23, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.